comprehensive -WSS

comprehensive

author：Wikipedia 2025-09-03 05:36:04 - browse：945

Feng Zhang Editas — Aera was formed to pursue a nanoparticle described by Feng Zhang in 2021. Susan Walsh/AP

Aera Therapeutics, a startup launched by the CRISPR pioneer Feng Zhang last year to solve one of the biggest bottlenecks in genetic medicine, has laid off a quarter of its staff, the company confirmed to STAT.

The layoffs come as the biotech market remains mired in a now nearly three-year-long downturn that has left startups struggling to attract both private and public funds. Aera attributed the layoffs to those headwinds and indicated it had axed a portion of the company dedicated to developing new gene-editing enzymes.

“In 2023, Aera launched to pursue an ambitious mission to develop transformative genetic medicines by harnessing enabling delivery technologies and precision payloads,” spokesman Dan Budwick said in a statement. “Although Aera remains in a strong cash position today, given the current biotech funding environment, we have chosen to take steps to focus our strategy and investments on the development of our novel delivery platforms, thereby further extending our cash runway.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Menendez indictment could see pharma lose a key ally

WSS

ADA: All diabetes patients should be screened for liver condition

Lilly’s obesity pill cuts 15% of weight at highest dose in mid

After a drawn out lobbying fight, ARPA

Prince Harry seeks over $550,000 in phone hacking lawsuit against British tabloid publisher

Medicaid, Medicare dual

Medicaid, Medicare dual

knowledge

comprehensive

hotspot

BioMarin wins approval for gene therapy to treat hemophilia A

New lesbian bars spark hope amid disappearing LGBTQ+ spaces

What does generative AI mean for health care? We asked experts

GOP inquiry over gain

Hepatitis C has a cure — but many Americans still lack access to it

Synthetic human embryos? Researchers say term is overblown

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Senator probes 340B programs at Cleveland Clinic, Bon Secours

How to save PrEP access — and even expand it

What Wagner Group's armed rebellion could mean for Russia's endgame in Ukraine

leisure time

Mindstrong's demise and the future of mental health care

Ionis has late

Shingles, which affected Dianne Feinstein, is on the rise

Health tech startups drop sharply from 2021 highs

Paxlovid should be available without a positive Covid test

Menendez indictment could see pharma lose a key ally

focus

explore

hotspot

hotspot